Texas Diabetes Institute

San Antonio, Texas 78284

1 studies enrolling now · 12 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glucose Tolerance Impaired, Impaired Glucose Tolerance, Insulin Sensitivity, Obesity, Overweight, Type 2 Diabetes, Type 2 Diabetes Mellitus, Type1diabetes

Studies at this site

• SGLT2i, Pioglitazone, and Ketone Production in T1D — Recruiting now
• STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss — Running, not enrolling
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus — Completed
• Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM — Completed
• Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM — Completed
• Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM — Completed
• Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes — Completed
• Actos Now for Prevention of Diabetes (ACT NOW) — Completed
• An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial — Completed
• Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM — Completed
• Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population — Completed
• Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients — Completed